Dr. Ehman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Nuclear Medicine, 2017 - 2018
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Abdominal Radiology, 2016 - 2017
University of California (San Francisco)Residency, Radiology-Diagnostic, 2012 - 2016
Santa Clara Valley Medical CenterInternship, Transitional Year, 2011 - 2012- Mayo Clinic College of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - Present
AZ State Medical License 2019 - 2027
IA State Medical License 2019 - 2026
FL State Medical License 2019 - 2025
MN State Medical License 2016 - 2025
WI State Medical License 2019 - 2025
MA State Medical License 2017 - 2018- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 9 citationsVenous invasion by hepatic tumors: imaging appearance and implications for managementScott M. Thompson, Michael L. Wells, James C. Andrews, Eric C. Ehman, Christine O. Menias
Abdominal Radiology. 2018-08-01 - 53 citationsEarly detection of multiorgan light-chain amyloidosis by whole-body 18F-florbetapir PET/CTEric C. Ehman, M. Samir El-Sady, Marie Foley Kijewski, Yiu Ming Khor, Sophia Jacob
Journal of Nuclear Medicine. 2019-09-01 - 161 citations68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar-Oromieh, Rahul Aggarwal
Journal of Nuclear Medicine. 2017-01-01
Authored Content
- Borderline Resectable and Locally Advanced Pancreas Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Neoadjuvant Therapy Pathologic Response and Prediction of SurvivalOctober 2020
Press Mentions
Mayo Clinic to Lead New Radiotracer Trial for Detecting Pancreatic CancerJanuary 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
